Hollis D Showalter

4PUBLICATIONS
4CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 30, 2022
Optimization of Benzoxazinorifamycins to Improve Mycobacterium tuberculosis RNA Polymerase Inhibition and Treatment of Tuberculosis.

Walajapet Rajeswaran, Shireen R Ashkar, Pil H Lee

|Jun 30, 2022
Optimization of Benzoxazinorifamycins to Minimize hPXR Activation for the Treatment of Tuberculosis and HIV Coinfection.

Shireen R Ashkar, Walajapet Rajeswaran, Pil H Lee

|Sep 15, 2020
Recent Progress in the Discovery and Development of 2-Nitroimidazooxazines and 6-Nitroimidazooxazoles to Treat Tuberculosis and Neglected Tropical Diseases.

Hollis D Showalter

|Mar 05, 2019
Synthesis of deuterium-labelled amlexanox and its metabolic stability against mouse, rat, and human microsomes.

Xinmin Gan, Michael W Wilson, Tyler S Beyett

Pageof 1

Frequent Collaborators

2 joint publications

Shireen R Ashkar

2 joint publications

Scott G Franzblau

2 joint publications

George A Garcia

1 joint publications

Yeonoh Shin